MX2009012140A - Procesamiento de polisacaridos naturales mediante microorganismos no patogenos seleccionados y metodos de fabricacion y uso de los mismos. - Google Patents

Procesamiento de polisacaridos naturales mediante microorganismos no patogenos seleccionados y metodos de fabricacion y uso de los mismos.

Info

Publication number
MX2009012140A
MX2009012140A MX2009012140A MX2009012140A MX2009012140A MX 2009012140 A MX2009012140 A MX 2009012140A MX 2009012140 A MX2009012140 A MX 2009012140A MX 2009012140 A MX2009012140 A MX 2009012140A MX 2009012140 A MX2009012140 A MX 2009012140A
Authority
MX
Mexico
Prior art keywords
making
methods
processing
same
natural polysaccharides
Prior art date
Application number
MX2009012140A
Other languages
English (en)
Inventor
Robert A Sinnott
Original Assignee
Mannatech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mannatech Inc filed Critical Mannatech Inc
Publication of MX2009012140A publication Critical patent/MX2009012140A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/02—Monosaccharides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/12—Disaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Botany (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La presente invención incluye composiciones y métodos de fabricación y uso de un complemento dietético manufacturado a partir de uno o más polisacáridos naturales previamente incubados con una bacteria prebiótica en un sistema de bioreactor, en donde las bacterias procesan los polisacáridos y los polisacáridos procesados resultantes son provistos en el complemento nutricional.
MX2009012140A 2007-05-11 2008-05-09 Procesamiento de polisacaridos naturales mediante microorganismos no patogenos seleccionados y metodos de fabricacion y uso de los mismos. MX2009012140A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91733907P 2007-05-11 2007-05-11
PCT/US2008/063329 WO2008141240A1 (en) 2007-05-11 2008-05-09 Processing of natural polysaccharides by selected non-pathogenic microorganisms and methods of making and using the same

Publications (1)

Publication Number Publication Date
MX2009012140A true MX2009012140A (es) 2009-12-11

Family

ID=40002629

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009012140A MX2009012140A (es) 2007-05-11 2008-05-09 Procesamiento de polisacaridos naturales mediante microorganismos no patogenos seleccionados y metodos de fabricacion y uso de los mismos.

Country Status (14)

Country Link
US (3) US9415056B2 (es)
EP (2) EP2155768B1 (es)
JP (1) JP2010526539A (es)
KR (1) KR101493302B1 (es)
CN (1) CN101687897A (es)
AR (1) AR066900A1 (es)
AU (1) AU2008251346B2 (es)
BR (1) BRPI0811131A2 (es)
CA (1) CA2687083A1 (es)
MX (1) MX2009012140A (es)
NZ (1) NZ581043A (es)
TW (1) TW200904340A (es)
WO (1) WO2008141240A1 (es)
ZA (1) ZA200908063B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2155147B1 (en) * 2007-05-11 2015-10-28 Woodcliff Skincare Solutions, Inc. Aloe preparation for skin enhancement
US10644163B2 (en) * 2008-08-27 2020-05-05 Idemitsu Kosan Co., Ltd. Semiconductor film comprising an oxide containing in atoms, Sn atoms and Zn atoms
US7833829B2 (en) * 2008-10-28 2010-11-16 Honeywell International Inc. MEMS devices and methods of assembling micro electromechanical systems (MEMS)
JP5606672B2 (ja) * 2008-11-26 2014-10-15 太陽化学株式会社 シンバイオティクスを利用した腸内環境調整方法
JP2010273569A (ja) * 2009-05-26 2010-12-09 Wasaburo Sato メタボリックシンドローム改善作用を有する飲料及びサプリメント
US8580278B2 (en) 2009-06-03 2013-11-12 Trustees Of Dartmouth College Nutraceutical composition and methods for preventing or treating multiple sclerosis
US20100311686A1 (en) * 2009-06-03 2010-12-09 Kasper Lloyd H Nutraceutical composition and methods for preventing or treating multiple sclerosis
FR2955774A1 (fr) 2010-02-02 2011-08-05 Aragan Preparation destinee a traiter l'exces ponderal et les desordres associes et applications de ladite preparation
JP6273200B2 (ja) 2011-07-12 2018-01-31 ザ・ブリガーム・アンド・ウーメンズ・ホスピタル・インコーポレーテッド 脂質含有ｐｓａ組成物、その単離の方法および使用の方法
CN110201003A (zh) 2012-02-29 2019-09-06 伊西康内外科公司 微生物区系的组合物及与其相关的方法
CA3008794C (en) 2012-03-29 2021-03-16 Therabiome, Llc Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
WO2014074770A2 (en) 2012-11-09 2014-05-15 Heliae Development, Llc Balanced mixotrophy methods
WO2014074772A1 (en) 2012-11-09 2014-05-15 Heliae Development, Llc Mixotrophic, phototrophic, and heterotrophic combination methods and systems
CA2904389C (en) 2013-03-14 2018-09-18 Jerome J. Schentag Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
EP2876167A1 (en) * 2013-11-21 2015-05-27 Institut Gustave Roussy Microbiota composition, as a marker of responsiveness to chemotherapy, and use of microbial modulators (pre-,pro- or synbiotics) for improving the efficacy of a cancer treatment
SG10201903823QA (en) 2014-10-31 2019-05-30 Whole Biome Inc Methods and compositions relating to microbial treatment and diagnosis of disorders
EP3337321A4 (en) 2015-08-19 2019-07-17 President and Fellows of Harvard College LIPIDED PSA COMPOSITIONS AND METHOD
WO2018014012A1 (en) 2016-07-15 2018-01-18 President And Fellows Of Harvard College Glycolipid compositions and methods of use
WO2019046646A1 (en) 2017-08-30 2019-03-07 Whole Biome Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
EP3766359A4 (en) * 2018-03-16 2021-12-15 Ajinomoto Co., Inc. FEED ADDITIVES AND FEED
US11401536B2 (en) * 2018-05-31 2022-08-02 Ngee Ann Polytechnic D-psicose production using probiotic microorganisms
US11273123B2 (en) 2018-07-18 2022-03-15 USpharma Ltd Chewable pharmaceutical dosage forms
CN111820419B (zh) * 2020-07-24 2022-05-27 中国海洋大学 靶向调控肠道艾克曼菌和短链脂肪酸产生菌的组合物
CN111961698A (zh) * 2020-08-27 2020-11-20 桂林理工大学 一种利用短乳杆菌产酶降解西番莲果皮多糖的制备方法及其应用
CN112501049B (zh) * 2020-10-28 2022-04-19 石河子大学 产转糖基活性β-半乳糖苷酶的开菲尔乳杆菌及制备的β-半乳糖苷酶生产低聚半乳糖的方法
CN112741272B (zh) * 2021-01-18 2023-02-28 黑龙江中医药大学 一种高含量纳豆激酶的纳豆冻干粉的发酵方法
CN113303475B (zh) * 2021-06-18 2022-06-14 湖南营养树生物科技有限公司 一种功能性益生菌剂及其制备方法
CN115261426B (zh) * 2022-09-26 2023-01-03 东北农业大学 一种具有抗氧化能力的两歧双歧杆菌e3胞外多糖

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5443830A (en) 1982-05-07 1995-08-22 Carrington Laboratories, Inc. Drink containing mucilaginous polysaccharides and its preparation
JPS60149527A (ja) 1984-01-17 1985-08-07 Seikenkai 生体内脱臭剤
US5000939A (en) 1984-06-12 1991-03-19 Colgate-Palmolive Company Dentifrice containing stabilized enzyme
EP0311469A3 (en) 1987-09-02 1990-05-30 Plant Genetic Systems N.V. Transformed lactic acid bacteria
US5079018A (en) 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
DK469989D0 (da) 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
US5045314A (en) 1989-11-14 1991-09-03 The United States Of America As Represented By The Secretary Of Agriculture Control of parasitic nematode ova/larvae with a bacillus laterosporus
JP3172177B2 (ja) 1990-11-14 2001-06-04 イミュー プロダクツ ウェスターン オーストレイリア ピーティーワイ． リミテッド エミュー油から誘導した抗炎性混合物
CA2109218A1 (en) 1991-05-02 1992-11-03 Kurt Dorreich Rhamnogalacturonase, corresponding dna sequence, rhamnogalacturonase containing enzyme preparation and use of the enzyme preparation
IT1262927B (it) 1992-01-14 1996-07-22 Consiglio Nazionale Ricerche Batteri sporgenti e loro impiego come probiotici
KR950001449B1 (ko) * 1992-07-03 1995-02-24 풀무원식품주식회사 알로에를 주원료로 한 건강보조식품의 제조방법
US5409703A (en) 1993-06-24 1995-04-25 Carrington Laboratories, Inc. Dried hydrogel from hydrophilic-hygroscopic polymer
DK83993D0 (es) * 1993-07-13 1993-07-13 Novo Nordisk As
KR0128714B1 (ko) * 1994-07-25 1998-04-04 한동근 산 생성능이 우수한 락토바실러스속 변이주 및 그를 이용한 녹차 발효음료의 제조방법
AUPM823094A0 (en) * 1994-09-16 1994-10-13 Goodman Fielder Limited Probiotic compositions
US6241983B1 (en) * 1994-10-28 2001-06-05 Metagenics, Inc. Bacteria-and fiber-containing composition for human gastrointestinal health
US5830884A (en) 1995-01-18 1998-11-03 National Starch And Chemical Investment Holding Corporation Pharmaceutical products containing thermally-inhibited starches
US5902796A (en) * 1995-09-22 1999-05-11 Carrington Laboratories, Inc. Bioactive factors of aloe vera plants
US5760102A (en) 1996-02-20 1998-06-02 Carrington Laboratories, Inc. Uses of denture adhesive containing aloe extract
US6929807B1 (en) 1996-08-09 2005-08-16 Mannatech, Inc. Compositions of plant carbohydrates as dietary supplements
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
ES2255730T3 (es) 1997-04-18 2006-07-01 Ganeden Biotech, Inc. Utilizacion topica de esporas de bacilos probioticos para prevenir o tratar las infecciones microbianas.
DE19730538A1 (de) * 1997-07-16 1999-01-21 Niggemann Barb Wohlschmeckende Gärzubereitung
KR100387245B1 (ko) * 1997-10-17 2003-08-19 일양약품주식회사 유산균의안정화를위한미세장용성코팅과립
US6203797B1 (en) 1998-01-06 2001-03-20 Stephen C. Perry Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome
US5928664A (en) * 1998-02-11 1999-07-27 Fuisz Technologies Ltd. Consumable gummy delivery system
NL1010770C2 (nl) * 1998-12-09 2000-06-13 Nutricia Nv Preparaat dat oligosacchariden en probiotica bevat.
US6468525B1 (en) 1999-08-10 2002-10-22 Renew Life, Inc. Probiotic formulation
US6383482B1 (en) * 2000-08-24 2002-05-07 Vitacost.Com, Inc. Weight loss composition containing green tea, hydroxycitric acid, 5-hydroxytryptophan, glucomannan, picolinate and lactobacillus
US6586032B2 (en) * 2000-10-12 2003-07-01 Cp Kelco U.S. Inc. Gelatin-free gummy confection using gellan gum and carrageenan
JP4009928B2 (ja) * 2000-11-15 2007-11-21 カルピス株式会社 グルコマンナンゾル入り酸性乳性飲料
IL156490A0 (en) * 2000-12-18 2004-01-04 Probiohealth Probiotic compounds derived from lactobacillus casei strain ke01
JP2004520318A (ja) * 2000-12-27 2004-07-08 エヌ・ヴイ・ヌートリシア オリゴ糖を含有する健康増進作用を有する栄養組成物
US6864231B2 (en) 2001-01-09 2005-03-08 Pharmachem Laboratories, Inc. Glycoprotein matrix compositions and methods related thereto
US20030185811A1 (en) * 2001-02-06 2003-10-02 Steve Teasdale Herbal extract and preparation thereof
PL205155B1 (pl) * 2001-02-19 2010-03-31 Nestle Sa Jadalny suchy produkt oraz sposób jego wytwarzania
US20070098784A1 (en) * 2001-09-28 2007-05-03 Nutraceutix, Inc. Delivery system for biological component
KR100979877B1 (ko) 2001-09-28 2010-09-02 뉴트라슈틱스 인코포레이티드 생물학적 성분의 전달 시스템
ATE371442T1 (de) * 2001-10-12 2007-09-15 Elan Pharma Int Ltd Zusammensetzungen mit einer kombination aus eigenschaften sofortiger freisetzung und kontrollierter freisetzung
WO2003041512A1 (en) * 2001-11-12 2003-05-22 Mars, Incorporated Foodstuff
AU2002351576A1 (en) * 2001-12-13 2003-07-09 Ism Biopolymer Inc. Method of modulating release of saccharides and uses thereof
ES2451618T3 (es) * 2001-12-20 2014-03-28 Biolactis Inc. Matriz de proteína maleable y usos de estas
US20030175370A1 (en) 2002-03-07 2003-09-18 Carrington Laboratories, Inc. Dispersed solid-containing complex carbohydrate
US20050074442A1 (en) * 2002-03-13 2005-04-07 Natarajan Ranganathan Compositions and methods for augmenting kidney function
US6894231B2 (en) * 2002-03-19 2005-05-17 Broadcom Corporation Bus twisting scheme for distributed coupling and low power
US8119376B2 (en) * 2002-05-14 2012-02-21 Purac Biochem B.V. Method for the production of lactic acid or a salt thereof by simultaneous saccharification and fermentation of starch
US7182943B2 (en) * 2002-05-15 2007-02-27 UNIVERSITé LAVAL Method and system for modulation of microbial cell characteristics
US20040005304A1 (en) * 2002-07-08 2004-01-08 Mak Wood, Inc. Novel compositions and methods for treating neurological disorders and associated gastrointestinal conditions
JP2004081105A (ja) * 2002-08-27 2004-03-18 Q'sai Co Ltd 便秘改善食品
FI119429B (fi) * 2002-09-17 2008-11-14 Danisco Hiilihydraattien uusi käyttö ja koostumukset
DE50301439D1 (de) * 2003-09-18 2005-11-24 Pm Internat Ag Luxemburg Luxem Pulver zum Ansatz für eine probiotische Joghurtspeise
PL1675481T3 (pl) * 2003-10-24 2009-03-31 Nutricia Nv Kompozycja synbiotyczna dla niemowląt
US20050239706A1 (en) 2003-10-31 2005-10-27 Washington University In St. Louis Modulation of fiaf and the gastrointestinal microbiota as a means to control energy storage in a subject
GB0410785D0 (en) * 2004-05-14 2004-06-16 Glycologic Ltd Improved prebiotic
US20060093592A1 (en) * 2004-10-04 2006-05-04 Nutracea Synbiotics
WO2006055711A1 (en) * 2004-11-18 2006-05-26 Kent Hann Compositions containing aloe vera isolate and a prebiotic and their therapeutic application
US20060228448A1 (en) * 2005-04-11 2006-10-12 The Iams Company Pet food compositions comprising two components
FR2887121B1 (fr) * 2005-06-17 2014-03-21 Gervais Danone Sa Produits laitiers frais a pouvoir satietogene a base de fibres hydrosolubles et procedes de preparation
TWI362949B (en) * 2005-09-13 2012-05-01 Bion Tech Inc Intestines dissolving nature is able to bear the hydrochloric acid in gastric juice and wrap up the benefit covered and grow the fungus of makes up
US20070071817A1 (en) * 2005-09-26 2007-03-29 Phyzz, Inc. Effervescent oral care compositions and method of use
AU2006294580B2 (en) * 2005-09-28 2012-07-26 E. & J. Gallo Winery Grape extract, dietary supplement thereof, and processes therefor
JP2008019170A (ja) * 2006-07-10 2008-01-31 Unitika Ltd 胃腸障害改善・予防作用を有する飲食品
KR100814067B1 (ko) 2007-05-30 2008-03-14 (주)엠비즈코리아 에스엠에스 메시지 열람확인 방법 및 이를 수행하기 위한단말장치

Also Published As

Publication number Publication date
CA2687083A1 (en) 2008-11-20
AU2008251346A1 (en) 2008-11-20
CN101687897A (zh) 2010-03-31
NZ581043A (en) 2011-11-25
EP2155768A4 (en) 2014-02-19
AU2008251346B2 (en) 2012-11-22
BRPI0811131A2 (pt) 2014-12-23
TW200904340A (en) 2009-02-01
KR20100017731A (ko) 2010-02-16
ZA200908063B (en) 2010-09-29
EP3170410A2 (en) 2017-05-24
US20170173067A1 (en) 2017-06-22
AR066900A1 (es) 2009-09-23
WO2008141240A1 (en) 2008-11-20
JP2010526539A (ja) 2010-08-05
KR101493302B1 (ko) 2015-02-13
US20150306121A1 (en) 2015-10-29
US20080286252A1 (en) 2008-11-20
EP3170410A3 (en) 2017-06-21
EP2155768B1 (en) 2017-05-03
US9415056B2 (en) 2016-08-16
US10117884B2 (en) 2018-11-06
US9855288B2 (en) 2018-01-02
EP2155768A1 (en) 2010-02-24

Similar Documents

Publication Publication Date Title
MX2009012140A (es) Procesamiento de polisacaridos naturales mediante microorganismos no patogenos seleccionados y metodos de fabricacion y uso de los mismos.
GB0906322D0 (en) Immobilized product tolerant microorganisms
PT1740726E (pt) Detecção e tipagem de estirpes bacterianas de lactobacillus
PL1753440T3 (pl) Forma do podawania doustnego zawierająca bakterie probiotyczne
MX2013007736A (es) Una composicion nutricional que comprende fibra y probioticos para reducir sintomas intestinales relacionados con estres.
WO2010066012A3 (en) Nutriment containing arabinoxylan and oligosaccharides
MX356086B (es) Produccion de acidos grasos y derivados de los mismos.
MX2009009371A (es) Produccion mejorada de derivados de acidos grasos.
MX361006B (es) Inoculantes microbianos y composiciones fertilizantes que comprenden los mismos.
PL1841332T5 (pl) Kompozycja zagęszczacza dla pacjentów z trudnością połykania
NZ598751A (en) Anti-obesity agent, anti-obesity food or beverage, glucose tolerance-ameliorating agent, and food or beverage for amelioration of glucose tolerance (bifidobacterium breve mcc1274 (ferm bpp-11175))
DK2016169T3 (da) Solvent-tolerante mikroorganismer og fremgangsmåder til isolering
MY187676A (en) Microorganisms for the production of 1,4-butanediol and related methods
MX337838B (es) Secuencias de repetidos palindromicos cortos regularmente intercalados agrupados de bifidobacterias.
MX2008013794A (es) Dispersiones homogeneas que contienen pulpa de citrico y aplicaciones de las mismas.
TN2010000270A1 (en) Process for the production of algal biomass with a high lipid content
MX338201B (es) Bacterias acidolacticas de postacidificion baja.
MY148671A (en) Long-term enteral feed for maintenance
WO2016071505A9 (en) Microbial production of the flavonoids garbanzol, resokaempferol and fisetin
UA106372C2 (en) Enzymatic complex
EP3839053A3 (en) Genetically modified microorganisms having improved tolerance towards l-serine
PH12017502042A1 (en) Dietary supplement
MX2019014315A (es) Bacterias probioticas preacondicionadas en un medio que contiene gos y uso de estas.
IN2012DN06392A (es)
MY156694A (en) Producing edible residues from ethanol production

Legal Events

Date Code Title Description
FG Grant or registration